For instance, Lin and colleagues observed that mirabegron, a β3-AR agonist, could activate the BAT and inhibit the release of exosomal iNOS in the angiotensin II (Ang II)-induced mouse cardiac hypertrophy model [45]. The gene discussed is ADRB3; the disease is cardiac hypertrophy.